Litcius/Paper detail

PSMA- and GRPR-Targeted PET: Results from 50 Patients with Biochemically Recurrent Prostate Cancer

Lucia Baratto, Hong Song, Heying Duan, Negin Hatami, H.P. Bagshaw, Mark K. Buyyounouski, Steven Hancock, Sumit Shah, Sandy Srinivas, Patrick S. Swift, Farshad Moradi, Guido Davidzon, Andrei Iagaru

2021Journal of Nuclear Medicine66 citationsDOIOpen Access PDF

Abstract

In alignment with the International Council of Harmonization’s strategic goals, a public-private consortium has developed a structured template for planning and reporting on the implementation of real world evidence (RWE) studies of the safety and effectiveness of treatments. The template serves as a guiding tool for designing and conducting reproducible RWE studies; set clear expectations for transparent communication of RWE methods; reduce misinterpretation of prose that lacks specificity; allow reviewers to quickly orient and find key information; and facilitate reproducibility, validity assessment, and evidence synthesis. The template is intended for use with studies of the effectiveness and safety of medical products and is compatible with multiple study designs, data sources, reporting guidelines, checklists, and bias assessment tools.

Topics & Concepts

MedicineProstate cancerGlutamate carboxypeptidase IIBiochemical recurrencePET-CTNuclear medicineRecurrent prostate cancerCancerInternal medicinePositron emission tomographyProstatectomyProstate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsProstate Cancer Diagnosis and Treatment